Search results for: Kenneth Arrow
Filter search results
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
…a scoping review and decision framework. Pharmacoeconomics, 33(3), 255-269. Meekings, K. N., Williams, C. S., & Arrowsmith, J. E. (2012). Orphan drug development: an economically viable strategy for biopharma R&D….
OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?
19 August 2019
…treat the illness, not the person. They chase narrow biomedical indicators, which, while important, don’t capture all that matters to the patient. Prof Stephen McKenna will review current methods of…
OHE’s Adrian Towse to Take Office as ISPOR President
3 June 2014
…information, economic analysis and outcomes research. ISPOR must lead the scientific developments necessary to respond to these needs. We must break out of the narrow perspective of focussing on very…
The NICE Health Technology Evaluation Manual: A Fresh Perspective Needed?
16 March 2022
…and should be presented separately from the main analysis, which always takes a narrow NHS/PSS perspective. In addition, no guidance was provided on how they should be measured or presented,…
Guest post: The Economics of Elevated Hospital Mortality at Weekends
14 July 2015
…could therefore narrow the gap between weekday and weekend death rates by raising mortality during the week. Applying the weekday death rate to the volume of emergency admissions at…
Pharmaceutical Research: the Case for Growth in Britain
1 July 1967
…narrow context of the National Health Service, the pharmaceutical industry may have been judged primarily on its ability to manufacture and supply good quality medicines at the lowest possible prices….
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
…Regulatory Policy Institute (RPI) Annual Conference, which explored the trade-offs between complexity and simplicity in competition and regulatory policy. He participated in a session with George Yarrow, Chairman of the…
Leukaemia: Towards Control
6 January 1980
…chemotherapy and the extension of facilities for bone marrow transplantation in Britain, an operation which if made more widely available and/or applicable might reduce further the number of leukaemia deaths…
Health, Education and General Practice
1 January 1986
…practice is a broad avenue rather than a narrow gangplank. Incidentally, the conclusions from the 1985 meeting form a sharp contrast to those from an earlier meeting organised by the…